Source: American journal of cardiology. Unidade: FM
Subjects: DOENÇAS CARDIOVASCULARES, INIBIDORES DE ENZIMAS, RECEPTORES DE ANGIOTENSINA, METANÁLISE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Lis Victoria Ravani et al. Angiotensin Receptor-Neprilysin Inhibitor Effects on Atherosclerotic Cardiovascular Disease Events: A Meta-Analysis of Randomized Controlled Trials. American journal of cardiology, v. 205, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/56030. Acesso em: 16 nov. 2024.APA
Carvalho, L. V. R., Gewehr, D. M., Calomeni, P. A. -K. B., Gauza, M. de M., Pereira, J., Cardoso, R., et al. (2023). Angiotensin Receptor-Neprilysin Inhibitor Effects on Atherosclerotic Cardiovascular Disease Events: A Meta-Analysis of Randomized Controlled Trials. American journal of cardiology, 205. doi:10.1016/j.amjcard.2023.07.154NLM
Carvalho LVR, Gewehr DM, Calomeni PA-KB, Gauza M de M, Pereira J, Cardoso R, Ribeiro HB, Bocchi EA. Angiotensin Receptor-Neprilysin Inhibitor Effects on Atherosclerotic Cardiovascular Disease Events: A Meta-Analysis of Randomized Controlled Trials [Internet]. American journal of cardiology. 2023 ; 205[citado 2024 nov. 16 ] Available from: https://observatorio.fm.usp.br/handle/OPI/56030Vancouver
Carvalho LVR, Gewehr DM, Calomeni PA-KB, Gauza M de M, Pereira J, Cardoso R, Ribeiro HB, Bocchi EA. Angiotensin Receptor-Neprilysin Inhibitor Effects on Atherosclerotic Cardiovascular Disease Events: A Meta-Analysis of Randomized Controlled Trials [Internet]. American journal of cardiology. 2023 ; 205[citado 2024 nov. 16 ] Available from: https://observatorio.fm.usp.br/handle/OPI/56030